Atsena Therapeutics Investors

42 investors on Angel Roster list Atsena Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, the United Kingdom and Ireland.

Investors are matched on the company name in their portfolio, so companies that share the name Atsena Therapeutics can appear together.

Investors listed
42
With verified email
57%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 40 Atsena Therapeutics investors

The most complete profiles first. Showing 40 of 42.

  • Ben ScruggsVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 46 more

    Verified email available

  • Caroline G.Verified

    Venture Capital, Investor · Ireland

    SeedHealth CareWearablesWellnessWomen Founded

    Portfolio: Shoulder Innovations, ProVerum Medical, Medisix Therapeutics, Gemini Therapeutics and 23 more

    Verified email available

  • Douglas ReedVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 46 more

    Verified email available

  • Jeff TerrellVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more

    Verified email available

  • John CrumplerVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 47 more

    Verified email available

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Ken HaasVerified

    Venture Capital, Advisor, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Louis BernemanVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Manny StockmanVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Robert AdelsonVerified

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 65 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • andrew sinclairVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Anurag AgarwalVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Kenneth NoonanVerified

    Venture Capital · Singapore

    Health CareWearablesWellnessWomen Founded

    Portfolio: Shoulder Innovations, Medisix Therapeutics, Gemini Therapeutics, Locanabio and 22 more

    Verified email available

  • Matt CohenVerified

    Venture Capital, University Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Michael DialVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Paul ManningVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Services

    Portfolio: LEXEO Therapeutics, Nanoview Biosciences, PatientsLikeMe, Candel and 6 more

    Verified email available

  • Robert MorffVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more

    Verified email available

  • Shelley ChuVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Tim HainesVerified

    Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Bali Muralidhar

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more

    Contact details available

  • Brian Gallagher, Jr.

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more

    Contact details available

  • Jason Lettmann

    Venture Capital, Investor · Ireland

    SeedHealth CareWearablesWellnessWomen Founded

    Portfolio: Shoulder Innovations, Medisix Therapeutics, Gemini Therapeutics, Locanabio and 27 more

    Contact details available

  • Kseniya Simpson, PhD

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more

    Contact details available

  • Kurt von Emster

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedInvestment ManagementLife Science

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Marc Singer

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 69 more

    Contact details available

  • Mike Carusi

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWellnessWomen Founded

    Portfolio: Shoulder Innovations, Medisix Therapeutics, Gemini Therapeutics, Locanabio and 24 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Vin Miles

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • William Harrington

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Jayson Rieger

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Services

    Portfolio: LEXEO Therapeutics, Nanoview Biosciences, PatientsLikeMe, Candel and 6 more

    Contact details available

  • John Heard

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Kirsten Leute

    Venture Capital, University Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Contact details available

  • Sarah Shackelton

    Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

See all 42 Atsena Therapeutics investors

Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.

Frequently asked questions

How many Atsena Therapeutics investors are on Angel Roster?

Angel Roster lists 42 Atsena Therapeutics investors. 24 of them (57%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (42), Private Equity Firms (16) and University Program Investors (8). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Atsena Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (12), Series B (8) and Series A (5).

Where are Atsena Therapeutics investors based?

Most are based in the United States (32), the United Kingdom (5) and Ireland (2).

Which companies have Atsena Therapeutics investors backed?

The most-backed portfolio companies among them are Chiasma (19), Effector Therapeutics (19), Vera Therapeutics (19), Q32 Bio (18) and Antiva Biosciences (17).

How do I contact Atsena Therapeutics investors?

Create a free Angel Roster account to search and filter all 42, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.